Literature DB >> 21855044

Body surface area-based dosing of 5-fluoruracil results in extensive interindividual variability in 5-fluorouracil exposure in colorectal cancer patients on FOLFOX regimens.

Jennifer Saam1, Gregory C Critchfield, Stephanie A Hamilton, Benjamin B Roa, Richard J Wenstrup, Rajesh R Kaldate.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21855044     DOI： 10.1016/j.clcc.2011.03.015

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  9 in total

1.  Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6.

Authors:  Rajesh R Kaldate; Abebe Haregewoin; Charles E Grier; Stephanie A Hamilton; Howard L McLeod
Journal:  Oncologist       Date:  2012-03-01

Review 2.  Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy.

Authors:  Jan H Beumer; Edward Chu; Carmen Allegra; Yusuke Tanigawara; Gerard Milano; Robert Diasio; Tae Won Kim; Ron H Mathijssen; Li Zhang; Dirk Arnold; Katsuki Muneoka; Narikazu Boku; Markus Joerger
Journal:  Clin Pharmacol Ther       Date:  2018-09-11       Impact factor: 6.875

3.  Evaluation of the 5-fluorouracil plasma level in patients with colorectal cancer undergoing continuous infusion chemotherapy.

Authors:  Yu Abe; Naoki Sakuyama; Tsuyoshi Sato; Kenji Kishine; Kiichi Nagayasu; Akinori Nakatani; Masayuki Kitajima; Tomoo Watanabe; Kazuhiko Nishimura; Takumi Ochiai; Isao Nagaoka
Journal:  Mol Clin Oncol       Date:  2019-07-03

4.  Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.

Authors:  Yuxiang Ma; Yuehao Lin; Benyan Zou; Wanli Liu; Yang Zhang; Liping Zhao; Yan Huang; Yunpeng Yang; Wenfeng Fang; Yuanyuan Zhao; Jin Sheng; Tao Qin; Zhihuang Hu; Salavatore J Salamone; Yunying Li; Li Zhang; Hongyun Zhao
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

Review 5.  Therapeutic drug monitoring of 5-fluorouracil.

Authors:  James J Lee; Jan H Beumer; Edward Chu
Journal:  Cancer Chemother Pharmacol       Date:  2016-05-23       Impact factor: 3.333

Review 6.  Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Georgia Pitsiou; Bernd Linsmeier; Drosos Tsavlis; Ioannis Kioumis; Eleni Papadaki; Lutz Freitag; Theodora Tsiouda; J Francis Turner; Robert Browning; Michael Simoff; Nikolaos Sachpekidis; Kosmas Tsakiridis; Bojan Zaric; Lonny Yarmus; Sofia Baka; Grigoris Stratakos; Harald Rittger
Journal:  J Cancer       Date:  2016-01-13       Impact factor: 4.207

Review 7.  Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic review.

Authors:  Karoline Freeman; Mark P Saunders; Olalekan A Uthman; Sian Taylor-Phillips; Martin Connock; Rachel Court; Tara Gurung; Paul Sutcliffe; Aileen Clarke
Journal:  BMC Cancer       Date:  2016-07-25       Impact factor: 4.430

8.  5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer.

Authors:  Katarzyna Morawska; Françoise Goirand; Laurine Marceau; Madeline Devaux; Adèle Cueff; Aurélie Bertaut; Julie Vincent; Leila Bengrine-Lefevre; François Ghiringhelli; Antonin Schmitt
Journal:  Oncotarget       Date:  2018-01-30

9.  Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy.

Authors:  Xingqin Zhou; Yazhou Chang; Jing Qian; Chaoyan Shen; Jie Han; Hongyu Zhao; Renan Chang
Journal:  Med Sci Monit       Date:  2021-07-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.